# Influence of Aspirin on Human Gut Microbiota Composition and Metabolome

> **NCT03450317** · NA · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 100 (estimated)

## Conditions studied

- Aspirin
- Microbiota

## Interventions

- **DRUG:** Aspirin 80mg

## Key facts

- **NCT ID:** NCT03450317
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03450317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03450317, "Influence of Aspirin on Human Gut Microbiota Composition and Metabolome". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT03450317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*